Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An efficient LASSO framework for admixture-aware polygenic scores.

HGG advances·2026
Same author

Multi-ancestry transcriptome prediction with functionally informed variants in TOPMed MESA improves performance of transcriptome-wide association studies.

American journal of human genetics·2026
Same author

Epigenome-wide association study meta-analysis of BMI in African Americans.

HGG advances·2025
Same author

Relationships among host genetics, gut microbiota, and asthma in US Hispanic/Latino adults.

Nature communications·2025
Same author

A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals.

BMC nephrology·2025
Same author

Genome-wide association study provides novel insight into the genetic architecture of severe obesity.

PLoS genetics·2025
Same journal

AI in variant analysis: fast track to genetic diagnoses.

Human genetics·2026
Same journal

Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorder.

Human genetics·2026
Same journal

Investigating the shared genetic architecture between selective immunoglobulin A deficiency and autoimmune diseases.

Human genetics·2026
Same journal

ARHI as a key regulator of EMT and metastasis in pancreatic cancer via the Notch-1 pathway.

Human genetics·2026
Same journal

Large-scale mitogenome analysis reveals complex maternal genetic connections between Sino-Tibetan- and Altaic-speaking populations.

Human genetics·2026
Same journal

Correction: A comprehensive and accessible model for co-segregation analysis in BRCA1, BRCA2, and PALB2 variant classification.

Human genetics·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Using public control genotype data to increase power and decrease cost of case-control genetic association studies.

Lindsey A Ho1, Ethan M Lange

  • 1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Human Genetics
|September 8, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a novel two-stage genome-wide association (GWA) study design. It enhances statistical power and reduces costs by using public control genotype data in the first stage, making GWA studies more accessible.

More Related Videos

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: Jun 9, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

  • Genetics
  • Bioinformatics
  • Statistical genetics

Background:

  • Genome-wide association (GWA) studies identify genetic risk factors for diseases.
  • High costs and low statistical power limit GWA study feasibility.
  • Current methods struggle with ancestry and batch effects when using public controls.

Purpose of the Study:

  • To compare statistical power and costs of different GWA study designs.
  • To introduce and evaluate a novel replication-based two-stage GWA design.
  • To control for type-I error inflation from public control data.

Main Methods:

  • Comparison of GWA study designs using cases and screened controls versus those incorporating public control data.
  • Description of a novel two-stage design using public controls in stage 1 and case-matched controls in stage 2.
  • Evaluation of statistical power, cost-effectiveness, and type-I error control.

Main Results:

  • The proposed two-stage design significantly increases statistical power.
  • The novel design substantially decreases the cost of performing GWA studies.
  • Type-I error rates are controlled despite potential ancestry and batch effects from public controls.

Conclusions:

  • The replication-based two-stage GWA design offers a cost-effective and powerful approach.
  • This design enhances accessibility to GWA studies for researchers.
  • The method effectively mitigates issues associated with using public control genotype data.